Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Semaglutide

STEP 5

Novo Nordisk · Phase 3 · Completed · Enrollment 304

NCT03693430

EudraCT 2017-003726-32

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Semaglutiden/rn/rn/rn/rn/r
Placebon/rn/rn/rn/rn/r
Semaglutide 2.4 mg, in trial81 participants46 participants53 participantsn/r1
Placebo, in trial33 participants7 participants36 participantsn/r0

A count stays a count. This page does not turn a count into a percent.